Oncoendocrinology: Metabolic consequences of androgen-deprivation therapy for prostate cancer with LHRH agonist
2020 ◽
Vol 12
(3)
◽
pp. 43-49
E.Yu. Gritskevich
◽
◽
T.Yu. Demidova
◽
M.R. Maturov
◽
A.A. Bystrov
◽
...
2014 ◽
Vol 13
(7)
◽
pp. e1567
I. Sokolakis
◽
A. Zarkadoulias
◽
K. Kazanas
◽
P. Georgopoulos
◽
K. Xouplidis
◽
...
2007 ◽
Vol 177
(4S)
◽
pp. 200-200
◽
Andrea Gallina
◽
Pierre I. Karakiewicz
◽
Jochen Walz
◽
Claudio Jeldres
◽
Quoc-Dien Trinh
◽
...
2007 ◽
Vol 177
(4S)
◽
pp. 335-335
◽
Matthew R. Smith
◽
F. Chu
◽
J. Forrest
◽
S. Bruce Malkowicz
◽
David Price
◽
...
2006 ◽
Vol 175
(4S)
◽
pp. 65-65
Tracey L. Krupski
◽
Kathleen A. Foley
◽
Onur Baser
◽
Stacey R. Long
◽
David Macarios
◽
...
2006 ◽
Vol 175
(4S)
◽
pp. 41-41
Matt C. Kincade
◽
Ithaar H. Derweesh
◽
John Malcolm
◽
Kimberly D. Lamar
◽
Anthony L. Patterson
◽
...
Abdallah Alzoubi
◽
Aya Alsmairat
◽
Bashir Samir Al
◽
Mahmoud Alfaqih
◽
Khalid Kheirallah
Laura Evangelista
◽
Fabio Zattoni
◽
Andrea Guttilla
◽
Umberto Basso
◽
Filiberto Zattoni
Alberto Dalla Volta
◽
Francesca Valcamonico
◽
Stefania Zamboni
◽
Vittorio D. Ferrari
◽
Salvatore Grisanti
◽
...
Alexander Bachmann
◽
Malte Rieken